Centro de Referencia Estatal de Atención Al Daño Cerebral
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Balance Dimensions-Based Rehabilitation Program in People With Acquired Brain Injury
Role: collaborator
Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury
Role: collaborator
Cross-cultural Adaptation to the Spanish Population and Validation of the Community Balance & Mobility Scale (S-CB&M)
Role: collaborator
Cross-cultural Adaptation to the Spanish Population and Validation of the BESTest and Mini-BESTest
Role: lead
Clinical Effectiveness of the ReHand App in Hand Rehabilitation After Stroke
Role: collaborator
Therapy to Improve Reaching Movement in Upper Limb
Role: collaborator
All 6 trials loaded